Biotechnology Expert Witnesses

California

Internal Medicine, Oncology - patents, biotechnology, pharmaceutical industry, internal medicine, oncology, endocrinology

Training include -Massachusetts General Hospital (Fellow) -Harvard Medical School Previous titles include NCI Cancer Center Director for 13 years Lombardi Cancer Center, Georgetown University. Sidney Kimmel Cancer Center, Thomas Jefferson University. Department Chairman of Oncology, Georgetown University. Department Chairman of Cancer Biology, Thomas Jefferson University. Executive Vice President Thomas Jefferson University. Ranked in the world as Highly Cited research scientist in breast cancer (#6), prostate cancer (#2) Recipient of research grants and multiple national awards. Elected Member American Society of Clinical Investigators. Gragnani Endowed Chair Order of Australia (Queen Elizabeth II) National Academy Europe National Academy Hungary Biotechnology Company Founder

Fort Lauderdale, Florida

Internal Medicine, Oncology - patents, biotechnology, pharmaceutical industry, internal medicine, oncology, endocrinology

Training include -Massachusetts General Hospital (Fellow) -Harvard Medical School Previous titles include NCI Cancer Center Director for 13 years Lombardi Cancer Center, Georgetown University. Sidney Kimmel Cancer Center, Thomas Jefferson University. Department Chairman of Oncology, Georgetown University. Department Chairman of Cancer Biology, Thomas Jefferson University. Executive Vice President Thomas Jefferson University. Ranked in the world as Highly Cited research scientist in breast cancer (#6), prostate cancer (#2) Recipient of research grants and multiple national awards. Elected Member American Society of Clinical Investigators. Gragnani Endowed Chair Order of Australia (Queen Elizabeth II) National Academy Europe National Academy Hungary Biotechnology Company Founder

Bethesda, Maryland

Pharmaceutical Research, DNA - Drug development, Gene therapy, Oligonucleotide, Drug manufacturing, Bioprocessing, Biologics, Biopharmaceuticals, Monoclonal antibodies, Peptides, Drug discovery, Biotechnology, Business valuation, Due diligence, Drug regulation, Therapeutics, Cell therapy, Drug research, Research and development, RNA therapeutics, Drug research

Management consultant and fractional management services to biopharma companies providing a broad set of services. Hands on management experience from Big Pharma, biotech companies, and as consultant COO for biotech companies. Consulting experience from Boston Consulting Group. Large industry network. Over 25 years broad experience in US, EU, Japan and Australia. Doctor of Science from MIT in Biochemical Engineering with minor in Management. Master of Science in Chemical Engineering from Royal Institute of Technology, Sweden. Consulting Experience from Boston Consulting Group, Arthur D. Little and IBM. Biopharma experience from Pharmacia, BASF Pharma and several biotech companies. Fulbright scholar. Member of the Umbrex, BiotechExcec and Alacrita consultant networks. Uniquely broad and deep experience both as a hands-on manager and consultant, in drug discovery, preclinical and clinical development (including IND filings and clinical trial management), biologics and gene thera...

Newton Center, Massachusetts

Financial, Pediatric Hematology Oncology - Appraisal and Valuation, Banking, Business Valuation, DNA, Financial, Securities and Investments, Biotechnology, Medical Devices, Healthcare Services, Life Science Tools, Pharmaceuticals, Entrepreneurial Companies, Start-up companies

Ilonna Rimm, MD PhD CFA, is a healthcare investor who has significant expertise related to the valuation of healthcare companies. She recently served as an expert witness related to the valuation of early-stage biotechnology companies. In addition to drafting the expert report and rebuttal, she served as a deponent, and she testified in the trial. As the CEO and Founder of Morninglight Healthcare Capital, LLC, a family office, she invests in small cap public companies (0 to $4B market cap). She also serves as an Advisor to Life Sciences CEO’s who are raising a Seed or Series A Round of capital, as Rimm Healthcare Capital Advisory, LLC. She recently provided services to Immuneering Corp., who raised a Series A round of $20M in January, 2020, and a Series B round of $62M in January, 2021. Immuneering is now a public company (IMRX). Ilonna currently works as a Financing Expert at the Harvard Innovation Lab, which is associated with Harvard Business School. Ilonna's advisory s...

Cambridge, Massachusetts

Regenerative Medicine, Biomedical Engineering - Regenerative Medicine, Cellular Therapies, Stem Cells, Extracellular Matrix, Perinatal Tissues (Placenta, Amnion, Chorion, Umbilical Cord Blood/Tissue), Transplantation, Cellular & Tissue Engineering, Biotechnology, Bioengineering, Medical Devices, Tissue Processing/Banking, HSCs, MSCs

Rouzbeh R. Taghizadeh, PhD, is a Cellular Therapy, Regenerative Medicine and Biomedical Engineering Expert offering more than 20 years of expertise as a Scientist, Innovator, and Entrepreneur in the development, processing, manufacturing of tissues, including bone marrow, umbilical cord (blood & tissue), amnion, chorion, placenta, adipose (fat), and other organs for clinical and non-clinical use, while considering the complex regulatory, trade secret, patent claims that arises from these areas. Litigation Support - Dr. Taghizadeh provides subject matter expertise and expert witness testimony for scientific, technical, regulatory, trade secret and patent claims in the areas of: Regenerative Medicine Blood / Tissue Banking Cellular and Tissue Based Therapeutics Stem Cell Bioengineering Extracellular Matrix HSCs / MSCs Processing Cryopreservation Longevity Cellular and Tissue Engineering Biotechnology Medical Devices Perinatal Tissues Transplantation Quality Control Regulatory and Po...

New York

Internal Medicine, Oncology - patents, biotechnology, pharmaceutical industry, internal medicine, oncology, endocrinology

Training include -Massachusetts General Hospital (Fellow) -Harvard Medical School Previous titles include NCI Cancer Center Director for 13 years Lombardi Cancer Center, Georgetown University. Sidney Kimmel Cancer Center, Thomas Jefferson University. Department Chairman of Oncology, Georgetown University. Department Chairman of Cancer Biology, Thomas Jefferson University. Executive Vice President Thomas Jefferson University. Ranked in the world as Highly Cited research scientist in breast cancer (#6), prostate cancer (#2) Recipient of research grants and multiple national awards. Elected Member American Society of Clinical Investigators. Gragnani Endowed Chair Order of Australia (Queen Elizabeth II) National Academy Europe National Academy Hungary Biotechnology Company Founder

Portland, Oregon

Toxicology - Alcohol Drug & DUI Testing, Chemicals, Food Safety, Hazardous Materials, Industrial Hygiene & Mold, Wrongful Death, Biology, Pesticides, Veterinary, Alcohol Abuse, Drug Abuse, Biotechnology, Aerosols, Agricultural, Addiction Medicine, Allergy & Immunology, Mass Torts, Personal Injury, Medical Toxicology, DNA

Dr. Carla Kinslow holds a doctorate in Biomedical Sciences, Cell Biology/Molecular Toxicology with over 35 years of biomedical, regulatory, and environmental experience. She has expertise in inhalation and oral toxicology; derivation of regulatory screening values for oral and inhalation exposure, toxicogenomics; toxicological risk assessment and communication of such risk to diverse stakeholders; human health impacts analysis from emission events; air, soil, and water monitoring data; modeling data related to ambient air and drinking water quality; water contamination from oil and gas operations; and stakeholder communication. She specializes in risk-based evaluation of air, soil, and groundwater toxicology under the USEPA, as well as state and federal guidelines. She has served as manager for various regulatory projects where she helped design and implement air monitoring networks, groundwater monitoring projects, and remediation scopes, with subsequent assessment and commun...

Providence, Rhode Island

Pharmaceutical Research, Chemistry & Chemicals - Drug Formulation, Biotechnology, liquid formulation, formulation, medicinal chemist, organic chemist, pharmacokinetics, stability studies, dietary supplements, tetracyclines, synthetic biology, drug tests, structure activity relationship, small molecule

EXPERT WITNESS CONSULTING Dr Abato has testified in high stakes litigation cases at the International Trade Commission on 2 occasions, the High Court of Malasia on 3 occasions in addition to Federal and State Courts. He has been deposed nine times and has been engaged as an expert in 10 cases pertaining to patent validity and infringement, ANDA/Paragraph IV disputes, trade secret misappropriation and trademark infringement disputes in cases related to pharmaceuticals. Upload Dr Abato’s CV, which includes a complete list of case numbers and Law Firms that he has represented. PHARMACEUTICAL EXPERIENCE Dr. Abato is a Medicinal Chemist. His expertise includes drug research, medicinal chemistry, organic chemistry, drug formulation for; IT, IV, IP, ICV, IN, IM and oral dosing routs, stability studies, extensive structure-activity relationships, efficacy, pharmacokinetics, as well as all pre-clinical testing required for IND submission to the FDA. Dr Abato was awarded the prest...

Charlottesville, Virginia

Medical Genetics, Forensic Science - Data science, Statistics, Genomics, Sequencing, DNA, Forensics, Research, AI, Synthetic biology, Biology, Biotechnology, Biosecurity, Biodefense, Public health, Infectious disease

Dr. Stephen D. Turner is an Associate Professor of Data Science and Dean of Research at the University of Virginia School of Data Science. Dr. Turner is an experienced genetics scientist, data science educator, and expert in bioinformatics, genomics, forensic science, and biotechnology. He holds a Ph.D. in Genetics, M.S. in Applied Statistics and has over 20 years of experience with DNA sequencing, bioinformatics, computational biology, genome editing, synthetic biology, forensic science, identity intelligence, human biomedical research, microbial genetics, public health, infectious disease genetics, and population-scale genomic data. He has served in academic, industry, and startup leadership roles. Dr. Turner is the author of over 100 peer-reviewed scientific publications and has taught graduate-level courses in data science, statistics, and computational biology. Dr. Turner has experience presenting complex scientific findings to both technical and non-technical audiences and is...